Cite

HARVARD Citation

    Pan, Z. et al. (2021). An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: Progress and opportunities. Current opinion in pharmacology. pp. 170-176. [Online]. 
  
Back to record